🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
🚀 This week’s podcast covers a wide range of Biotech updates 🧬 Topics include a new gene-editing therapy used in a rare pediatric case, progress in cell sorting technologies, and recent patent activity in therapeutic development. If you’re looking for a brief, clear summary of what’s happening in the space, this episode offers a helpful overview. 🎧 Listen here. #Biotech #LifeSciences #GeneTherapy #CRISPR #Healthcare #IndustryUpdate #Podcast #AI #NotebookLM Sources: Baby saved by gene-ed...
BioTech Weekly
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
